MRL Ventures Fund

The life sciences sector roared to the lead of the AW Research Deal Watch today as alts industry players across PE, VC and credit backed several biotech, diagnostics and medtech ventures in the U.S. and Europe today.

Divided by asset class, Alternatives Watch tracked a total of roughly $7.4 billion in deals publicly announced in the five-day period. Private equity: $6.2 billion Active Impact Investments, Lowercarbon Capital, Resilience Capital Partners, Skyview, Shell Ventures, and 3M Ventures (the venture capital ...

For the week ending January 10, Alternatives Watch has tracked more than $1.8 billion in private financing deals done by private equity firms, institutional investors and hedge funds in the life sciences arena. Some of the more well-known investors this ...

If anything could put a damper on the red-hot private market activity in healthcare, the Thanksgiving holiday did -- so much so that we didn't publish the Alts Watch Healthcare Beat (AWHB) roundup last week. Our combined two-week recon tallied ...

One deal towers above the rest in our look at the $1.41 billion private capital activity in healthcare for the week of Nov. 16-20. After operating as the venture capital arm of UK pharmaceutical giant GlaxoSmithKline (GSK) since 1985, SR ...